Nevada Chapter of the American College of Cardiology

ACCEL Lite: In-Hospital Initiation of Sodium Glucose Cotransporter-2 Inhibitors for Heart Failure with Reduced Ejection Fraction
Failure to initiate an SGLT2i to an eligible HFrEF patient exposes the patient to higher risk of early post-discharge death and readmission, and the real risk that the medication never gets prescribed at all.
DAPT Duration for High Bleeding Risk Patients After PCI
How do outcomes compare when patients receive 1 versus 3 months of dual antiplatelet therapy (DAPT) in high bleeding risk patients undergoing drug-eluting stent (DES) implantation?
Ticagrelor Versus Clopidogrel in CYP2C19 Loss-of-Function Carriers With Stroke or TIA
The goal of the CHANCE-2 trial was to assess ticagrelor and aspirin versus clopidogrel and aspirin in reducing risk of subsequent stroke among patients with stroke or high-risk transient ischemic attack (TIA) who were CYP2C19 loss-of-function carriers.
Post-PCI Physiology and Intravascular Imaging
The following are key points to remember from this state-of-the-art review on improving percutaneous coronary intervention (PCI) outcomes using postprocedural physiology and intravascular imaging.
Unoperated Severe Symptomatic Aortic Stenosis
What proportion of patients with severe, symptomatic, high-gradient aortic stenosis (AS) undergo intervention; and what clinical factors affect the decision not to intervene?